VBI Vaccines
VBIV
#10522
Rank
A$2.79 M
Marketcap
A$0.09749
Share price
0.00%
Change (1 day)
-90.16%
Change (1 year)

EPS for VBI Vaccines (VBIV)

EPS in 2024 (TTM): A-$15.27

According to VBI Vaccines 's latest financial reports the company's current EPS (TTM) is A-$15.14. In 2022 the company made an earnings per share (EPS) of A-$19.71 a decrease over its 2021 EPS that were of A-$12.09.

EPS history for VBI Vaccines from 1997 to 2024

Annual EPS

Year EPS Change
2024 (TTM)A-$15.27
2022A-$19.7162.96%
2021A-$12.0928.57%
2020A-$9.41-54.35%
2019A-$20.60-52.58%
2018A-$43.4410.23%
2017A-$39.4114.29%
2016A-$34.49-62.8%
2015A-$92.7190.68%
2014A-$48.62-7.95%
2013A-$52.82-57.97%
2012A-$125.69-78%
2011A-$571.413151.47%
2010A-$17.5723.87%
2009A-$14.19-18.48%
2008A-$17.4012.08%
2007A-$15.53-49.47%
2006A-$30.73
2005N/A-100%
2004A-$13.6611.94%
2003A-$12.21-81.89%
2002A-$67.40196.44%
2001A-$22.7384.33%
2000A-$12.33-65.37%
1999A-$35.62-29.45%
1998A-$50.4829.61%
1997A-$38.95

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Onconova Therapeutics
ONTX
A-$1.42-90.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Myriad Genetics
MYGN
A-$6.46-57.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Curis
CRIS
A-$5.48-63.81%๐Ÿ‡บ๐Ÿ‡ธ USA